HealthDay on MSN
ENDO: Few men receiving testosterone undergo guideline-concordant diagnostic testing
Few men who are prescribed testosterone therapy receive guideline-concordant diagnostic testing, according to a study ...
Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.
Automated software testing platform Testim has raised $10 million in a series B round of funding led by SignalFire, with participation from Lightspeed Venture Partners, Meron Capital, NHN Ventures, ...
We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. An at-home testosterone test can help people monitor ...
This article was reviewed by Felix Gussone, MD. If you've been feeling a bit more couch potato than go-getter lately, dragging through the day, snapping at people for no reason, or wondering where ...
Testosterone prescriptions quadrupled in the last 3 decades across the U.S. despite stable rates of male hypogonadism ...
2don MSN
Testosterone is being overprescribed to men — here's who should take it, and when it backfires
Getting testosterone therapy without the right medical care is a growing problem. Here's how to know if you need TRT, and ...
Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Tricentis, a software test automation ...
SAN FRANCISCO, Nov. 13, 2019 /PRNewswire/ -- Testim, the pioneer of codeless AI-based software testing in 2014, disrupts the industry once more with the announcement of the Testim Development Kit, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results